Regarding colorectal cancer cells, resistance to cetuximab-induced cell death in various CRC cell lines was determined by the activity of sphingosine kinase 1 (SPHK1) and the S1P/Cer ratio [30]. This evidence concerns the gene CBLN1 and colorectal carcinoma.